Bone marrow transplant program

At Children’s Wisconsin, our Bone Marrow Transplant Program is designed to offer both innovative treatment and compassionate care tailored to each patient’s needs. With decades of experience in treating pediatric cancers like leukemias and lymphomas, immune deficiencies, and non-malignant disorders such as hemoglobinopathies, our team ensures each child receives an individualized treatment plan.

We also offer access to cutting-edge clinical trials, providing patients with the latest in experimental treatments.

Meet the team

Our Bone Marrow Transplant Team, led by program director Julie-An Talano, MD, includes pediatric specialists, advanced practice providers, nurses, social workers, child life specialists, and more. The team collaborates to develop and execute treatment plans, ensuring every aspect of your child’s care is addressed.

Children’s Wisconsin also provides access to additional specialties, such as infectious disease care, cardiology, pulmonology, and critical care, ensuring your child’s needs are met.

The transplant process

  1. Initial Consultation: Your first visit at our MACC Fund Center involves meeting with the transplant team to discuss treatment options. If applicable, we will review participation in clinical trials for new therapies.
  2. Finding a Donor: Our team begins the process of finding a bone marrow donor, starting with family members. If no match is found, we search national and international registries for the best possible match.
  3. Pre-Transplant Testing: Before the transplant, several tests ensure your child’s health and readiness for the procedure.
  4. Transplant and Recovery: After chemotherapy and/or radiation to prepare the body, stem cells are infused into your child through an IV. Most patients remain in the hospital for 30 to 40 days, receiving care from our multidisciplinary team, including specialized amenities for comfort.  

Research and innovation

Our bone marrow transplant research team is actively exploring methods to improve transplant outcomes. This includes:

  • T-cell depletion: Reducing the risk of graft-versus-host disease by removing certain immune cells from the donor graft.
  • Improved survival outcomes: Ongoing studies focus on reducing transplant complications and enhancing patient recovery.

Children’s Wisconsin is committed to providing access to the latest treatments through our clinical trials, ensuring that patients receive the best possible care.